Lansoprazole
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00448 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 14 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | duodenogastric reflux | KG + DL |
| 2 | duodenal obstruction | KG + DL |
| 3 | gastrojejunal ulcer | KG + DL |
| 4 | peptic ulcer perforation | KG + DL |
| 5 | abnormality of glucagon secretion | KG + DL |
| 6 | gastroduodenitis | KG + DL |
| 7 | acne (disease) | KG + DL |
| 8 | Smouldering systemic mastocytosis | KG + DL |
| 9 | leather-bottle stomach | KG + DL |
| 10 | duodenitis | KG + DL |
| 11 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
| 12 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 13 | systemic mastocytosis | KG + DL |
| 14 | multiple endocrine neoplasia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.